Under construction – not a live service
Sign in
Taking people in GuadeloupeNo phase

Tracks care and outcomes of people with HIV in France over time

Collects long-term health and treatment data from adults with HIV at 15 French clinics.

Plain-language title generated from the registry record
Registry title: Quality of Care in French HIV Infected Patients

Key facts

Where
Pointe-à-Pitre, GuadeloupeSee the site

Where in Guadeloupe

  • CHU de GuadeloupePointe-à-Pitre, GuadeloupeTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
DatAids
Trial code
NCT02898987
Record updated
20 February 2026
Original description
The objective of the Dataids cohort is to continue a long-term, prospective collection of clinical, laboratory and therapeutic data on a large cohort of HIV infected patients seeking care in 15 HIV centers in France in order :Read full original descriptionShow less

Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients

The objective of the Dataids cohort is to continue a long-term, prospective collection of clinical, laboratory and therapeutic data on a large cohort of HIV infected patients seeking care in 15 HIV centers in France in order :

1. to provide and develop a surveillance system to describe clinical practice and temporal changes in the clinical course of HIV and HIV-related co-infections and co-morbidities in France. 2. to assess the factors associated with the clinical, immunological and virological course of HIV infection and HIV-related co-infections and co-morbidities

The specific objectives are as follows

* To continue surveillance of HIV infection in France to describe temporal changes * To evaluate the efficacy of ART and factors associated with ART efficacy * To monitor the uptake and outcome of HCV therapy

Inclusion: HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status.

Exclusion: Patients under 18 years of age; Patients without written informed consent.

ClinicalTrials.gov NCT02898987